STOCK TITAN

Mannatech Stock Price, News & Analysis

MTEX Nasdaq

Welcome to our dedicated page for Mannatech news (Ticker: MTEX), a resource for investors and traders seeking the latest updates and insights on Mannatech stock.

Mannatech Incorporated (MTEX) provides science-backed wellness solutions through nutritional supplements and skincare products across global markets. This page serves as the definitive source for official company announcements and market-relevant developments.

Investors and industry observers will find curated press releases covering financial results, product innovations, regulatory updates, and leadership changes. All content is maintained to reflect MTEX's position in the competitive wellness sector and its direct-to-consumer business model.

Key updates include earnings reports, research advancements in natural health formulations, and strategic partnerships. Regular monitoring of this resource enables stakeholders to track operational milestones and market expansion efforts across the Americas, EMEA, and Asia/Pacific regions.

Bookmark this page for streamlined access to MTEX's evolving corporate narrative. Combine these primary sources with broader market data for informed analysis of this wellness industry innovator.

Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) reported first quarter 2022 financial results with net sales of $32.4 million, a decline of 15.5% from $38.3 million in Q1 2021. On a constant dollar basis, net sales decreased by 11.5%. Supply chain issues led to deferred revenue of $0.9 million in Asia Pacific, affecting sales. Operating income fell to less than $0.1 million compared to $2.8 million in Q1 2021, while net income was $0.1 million, or $0.06 per diluted share. The number of fulfilled orders decreased by 6%, and recruitment of associates dropped by 5.1%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.17%
Tags
-
Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) reported Q4 2021 net sales of $39.5 million, up 0.8% from Q4 2020. Operating income improved to $1.0 million compared to an operating loss of $11.0 thousand in Q4 2020. Net income reached $2.6 million ($1.25 per diluted share), a significant increase from $0.7 million ($0.34 per diluted share) in the prior year. Gross profit margin improved to 77.5%. Year-end net sales increased 5.5% to $160.3 million, with net income for 2021 at $9.8 million ($4.71 per diluted share). The company returned $4.3 million in dividends and repurchased $5.1 million in stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
-
Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) has announced a cash dividend of $0.20 per share for its common stock. This dividend will be paid on March 30, 2022, to shareholders recorded by the close of business on March 16, 2022. The decision reflects the company's commitment to rewarding its investors and sustaining long-term interest in its stock. CEO Alfredo Bala emphasized the company's dedication to delivering shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
News
Rhea-AI Summary

Mannatech declared a cash dividend of $1.70 per share, payable on December 29, 2021, to shareholders of record on December 15, 2021. This dividend includes a quarterly portion of $0.20 and a special dividend of $1.50, highlighting the company's commitment to shareholder value. CEO Alfredo Bala emphasized the intent to reward and encourage long-term investment in Mannatech. With over 25 years in business and a presence in 25 markets, the company continues focusing on health and wellness products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
dividends
-
Rhea-AI Summary

Mannatech reported third quarter 2021 net sales of $39.4 million, a 3.9% increase from $38.0 million in Q3 2020. Income from operations rose to $3.3 million, compared to $1.4 million in the prior year. Net income reached $2.9 million, or $1.44 per diluted share, up from $1.6 million, or $0.76 per diluted share in Q3 2020. Year-to-date sales were $120.3 million, a 7.2% increase year-over-year. Recruitment of independent associates declined by 1.4% to 25,036 in Q3 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.48%
Tags
-
Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) has approved a share repurchase program to buy back up to $1.0 million of its outstanding common stock. The repurchase will occur in the open market or through negotiated transactions at management's discretion, influenced by market conditions. This initiative begins on September 21, 2021, and concludes either on September 21, 2022, or upon reaching the purchase limit. Mannatech plans to finance the repurchases using available cash, aiming to enhance shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.73%
Tags
buyback
Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) has declared a cash dividend of $0.20 per share, payable on September 29, 2021. This dividend is aimed at rewarding shareholders and promoting long-term investment. Shareholders on record as of September 15, 2021 will receive this dividend. CEO Alfredo 'Al' Bala emphasized the company's commitment to delivering value to its investors. Mannatech operates globally in the health and wellness sector, offering products through independent associates in over 25 markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
dividends
-
Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) reported a strong second quarter for 2021, achieving net sales of $42.5 million, a 12.9% increase from $37.6 million in Q2 2020. Operating income rose to $2.0 million from $1.1 million, while net income reached $2.1 million or $0.99 per diluted share, up from $1.1 million or $0.47 per share in the previous year. Recruitment of independent associates increased by 13.0% to 21,527. However, selling and administrative expenses also rose to $7.6 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.08%
Tags
-
Rhea-AI Summary

Mannatech, Incorporated (NASDAQ: MTEX) announced the completion of its cash tender offer, which concluded on June 25, 2021. The company purchased 171,433 shares of its common stock at $26.00 per share, totaling approximately $4.46 million. This represents around 8.31% of its total outstanding shares as of April 30, 2021. The purchase was funded through the company's cash reserves. Mannatech is devoted to enhancing lives with its health and wellness products through a network of independent associates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
none
Rhea-AI Summary

Mannatech (NASDAQ: MTEX) announced preliminary results of its cash tender offer to repurchase up to 211,538 shares at $26.00 each, which expired on June 25, 2021. A total of 169,622 shares were properly tendered, with the company expected to accept for payment 174,249 shares at a total cost of approximately $4.5 million, representing around 8.45% of its total outstanding shares. The purchase will be funded from cash on hand. Final numbers will be confirmed following a guaranteed delivery period.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.9%
Tags
none

FAQ

What is the current stock price of Mannatech (MTEX)?

The current stock price of Mannatech (MTEX) is $9.4 as of June 13, 2025.

What is the market cap of Mannatech (MTEX)?

The market cap of Mannatech (MTEX) is approximately 19.1M.
Mannatech

Nasdaq:MTEX

MTEX Rankings

MTEX Stock Data

19.12M
859.90k
49.28%
18.73%
0.73%
Food Distribution
Medicinal Chemicals & Botanical Products
Link
United States
FLOWER MOUND